• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AGA MEDICAL CORPORATION AMPLATZER SEPTAL OCCLUDER; CARDIAC OCCLUSION DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AGA MEDICAL CORPORATION AMPLATZER SEPTAL OCCLUDER; CARDIAC OCCLUSION DEVICE Back to Search Results
Device Problem Biocompatibility (2886)
Patient Problems Endocarditis (1834); Fever (1858); Mitral Regurgitation (1964)
Event Type  Injury  
Manufacturer Narrative
Events of vegetation and endocarditis were reported.The results of the investigation are inconclusive since the device was not returned for analysis.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed.Based on the information received, the cause of the reported incident could not be conclusively determined.Information from the field indicated that the patient had a history of atopic dermatitis.
 
Event Description
Complaint information from literature of the japanese society of pediatric cardiology and cardiac surgery (id# (b)(6)).On an unknown date, an amplatzer septal occluder (aso / unknown size) was implanted in a (b)(6) male patient.Six months later, the patient presented with fever and pain of the distal extremities.Infectious endocarditis was suspected and echocardiogram revealed vegetation on the aso and anterior cusp of the mitral valve.Mitral valve regurgitation was also observed due to the perforation of the anterior leaflet.Blood culture detected (b)(6)mri revealed multiple cerebral embolisms.The next day, an emergency procedure was performed to remove the vegetation and aso as well surgical closure of the atrial septal defect, and mitral valve repair.The patient was reported in good condition and discharged after antibiotic therapy for five weeks.Recurrence of the infection was not observed.Per physician's opinion, the patient's comorbidity (atopic dermatitis) was considered an infectious route.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMPLATZER SEPTAL OCCLUDER
Type of Device
CARDIAC OCCLUSION DEVICE
Manufacturer (Section D)
AGA MEDICAL CORPORATION
5050 nathan lane north
plymouth MN 55442
Manufacturer (Section G)
AGA MEDICAL CORPORATION
5050 nathan lane north
plymouth MN 55442
Manufacturer Contact
stephanie o' sullivan
5050 nathan lane north
plymouth, MN 55442
6517565400
MDR Report Key8073922
MDR Text Key127249762
Report Number2135147-2018-00213
Device Sequence Number1
Product Code MLV
Combination Product (y/n)N
Reporter Country CodeJA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial
Report Date 11/15/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 10/23/2018
Initial Date FDA Received11/15/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age21 YR
-
-